Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma

Table 1

Clinicopathological features of CKS2 expression in 156 HCC tissues.

Group		Pos. (%)	value	value
Age
≤50	80	66 (82.50)	1.777	0.183
>50	76	56 (73.68)
Gender
Female	19	14 (73.68)	0.259	0.611
Male	137	108 (78.83)
AFP (ng/mL)
≤20	61	49 (80.33)	0.265	0.607
>20	95	73 (76.84)
HBsAg
Negative	23	18 (78.26)	0.000	0.994
Positive	133	104 (78.20)
Tumor size
≤5 cm	83	63 (75.90)	0.551	0.458
>5 cm	73	59 (80.82)
Liver cirrhosis
Without	38	35 (92.11)	5.695	0.019
With	118	87 (73.73)
Differentiation degree
Well	44	29 (65.91)	5.436	0.020
Moderate & poor	112	93 (83.04)
Portal vein invasion
Without	61	57 (93.44)	13.645	<0.001
With	95	65 (68.42)
TNM
I & II	102	74 (72.55)	5.531	0.019
III & IV	54	48 (88.89)
Metastasis
Without	127	94 (74.02)	7.035	0.008
With	29	28 (96.55)
Recurrence
No	79	54 (68.35)	9.112	0.003
Yes	77	68 (88.31)

CKS2: cyclin-dependent kinase regulatory subunit 2; Pos. (%): positive number (%); TNM: tumor node metastasis; AFP: alpha-fetoprotein. Bold: .